“Kudos to President Trump for stepping up and taking the lead on this. PTSD is really a killer among veterans.”
By Rebecca Rivas, Missouri Independent
Missouri state Rep. Dave Griffith has spent the last five years digging into research on how psychedelic-assisted therapy has helped veterans struggling with post-traumatic stress disorder and depression.
This May marked the end of his final legislative session in the House, and he pushed one last time for legislation to allow clinical trials of psychedelic-assisted therapy in Missouri. In the final days of session, the bill stalled in the Missouri Senate, after passing with overwhelming support in the House.
“I’m not going to be there next year, I’m term-limited out,” said Griffith, a Republican who served as chairman of the House Veterans and Armed Forces Committee. “It’s really passing the torch to a lot of the other veterans that are on the Veterans Committee and those that see the value in it.”
He was hopeful when he saw an announcement from the U.S. Department of Veterans Affairs last week for a new clinical trial to evaluate the safety and efficacy of methylenedioxymethamphetamine-assisted therapy, or MDMA-assisted therapy. MDMA is a synthetic substance made in a lab, according to the department, and
Read full article on Marijuana Moment
